|
SMEK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68620672980069E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6581958028894E-11 |
| Normal-vs-Stage2 |
3.26230000013972E-07 |
| Normal-vs-Stage3 |
2.94875235340442E-12 |
| Normal-vs-Stage4 |
2.16471285341413E-12 |
| Stage1-vs-Stage2 |
7.920600E-01 |
| Stage1-vs-Stage3 |
3.660000E-02 |
| Stage1-vs-Stage4 |
9.724400E-03 |
| Stage2-vs-Stage3 |
1.113210E-01 |
| Stage2-vs-Stage4 |
2.253600E-02 |
| Stage3-vs-Stage4 |
4.081200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.8052226380405E-13 |
| Normal-vs-AfricanAmerican |
4.57460000002907E-06 |
| Normal-vs-Asian |
6.37420000115796E-08 |
| Caucasian-vs-AfricanAmerican |
7.516800E-01 |
| Caucasian-vs-Asian |
4.776000E-01 |
| AfricanAmerican-vs-Asian |
8.446600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.63219504157564E-11 |
| Normal-vs-Female |
1.7634782523146E-12 |
| Male-vs-Female |
6.885200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.4553003246931E-10 |
| Normal-vs-Age(41-60Yrs) |
4.1785463977817E-12 |
| Normal-vs-Age(61-80Yrs) |
2.95774515990388E-12 |
| Normal-vs-Age(81-100Yrs) |
7.78559999999873E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.222210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.510100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.331800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.441200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.926400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.574200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.775100E-04 |
| Classical-VS-Follicular |
5.018200E-01 |
| Classical-VS-Other |
9.250000E-01 |
| Classical-VS-Normal |
1.75329750717879E-11 |
| Tall-VS-Follicular |
1.014410E-02 |
| Tall-VS-Other |
9.524300E-02 |
| Tall-VS-Normal |
7.27973237246715E-12 |
| Follicular-VS-Other |
8.929800E-01 |
| Follicular-VS-Normal |
2.56440000345748E-08 |
| Other-VS-Normal |
6.735400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.89694959529652E-12 |
| Normal-vs-N1 |
3.80880005312889E-09 |
| N0-vs-N1 |
6.743000E-01 |
|
|
